Luxana Biotech is a preclinical antisense oligonucleotide (ASO) development company based on proprietary nucleic acids with unique cross-linking structures. We have created the LuxiAP™ ASO drug discovery platform for the central nervous system and ophthalmic fields. The company has collaborative research agreements with multiple pharmaceutical companies and maintains its own ASO pipeline. We are seeking to expand partnership opportunities not only for collaborative research with pharmaceutical companies but also for joint development utilizing our proprietary pipeline.
ルクサナバイオテク株式会社と住商ファーマインターナショナル株式会社によるルクサナバイオテクの人工修飾核酸アミダイトの製造販売に係るライセンスの契約を締結しましたのでお知らせします。 [画像: https://p...
[画像: https://prtimes.jp/i/49692/13/resize/d49692-13-40a38d37771416c2edb6-0.png ] 製薬会社・化学会社と協働し、有望な人工核酸を活用した核酸医薬創薬を目指すルクサナバイオテク株式会社（本社：大阪府...
[画像: https://prtimes.jp/i/49692/9/resize/d49692-9-51a392b4d1239b861316-0.png ]   ルクサナバイオテク株式会社（代表取締役社長CEO：佐藤秀昭、本社：大阪府吹田市、以下「ルクサナバイ...
[画像: https://prtimes.jp/i/49692/8/resize/d49692-8-540686c9ee246c06666b-0.png ] ルクサナバイオテク株式会社（代表取締役社長：佐藤秀昭、本社：大阪府吹田市、以下「ルクサナバイオテク」）は、武田薬...
  [画像: https://prtimes.jp/i/49692/6/resize/d49692-6-73d0358b1bc375d57266-0.png ] 新規人工核酸を駆使し有効性と安全性の高い核酸医薬品を開発するルクサナバイオテク株式会社（本社：大阪府吹...
[画像: https://prtimes.jp/i/49692/5/resize/d49692-5-fdbb342ebd6451f9a275-0.png ] ルクサナバイオテク株式会社（代表取締役 佐藤 秀昭、本社：大阪府、以下「ルクサナバイオテク」）は、2018 年 12 月に Al...
[画像: https://prtimes.jp/i/49692/4/resize/d49692-4-254796-0.png ] ルクサナバイオテク株式会社（本社：大阪府吹田市、代表取締役社長：佐藤 秀昭、以下「ルクサナバイオテク」）は、大日本住友製薬株...
[画像: https://prtimes.jp/i/49692/3/resize/d49692-3-360475-0.png ]     安全性と有効性の高い新規核酸医薬品を開発するルクサナバイオテク株式会社（本社：大阪府吹田市、代表取締役社長...
ルクサナバイオテク株式会社（本社：大阪府吹田市、代表取締役社長：佐藤 秀昭、以下「ルクサナバイオテク」）と学校法人愛知医科大学（本学：愛知県長久手市、以下「愛知医科大」）は、国立研究開発法人日本...
A startup from UCF’s School of Medicine applying exosome technology to regenerative medicine, drug delivery, non-invasive diagnostics, and medical device development. It aims to improve quality of life through innovative healthcare solutions for intractable diseases.
Elcyo develops innovative autofocal glasses that automatically adjust focus with proprietary lens technology. Leveraging Fresnel Liquid Crystal Lens Technology, Elcyo has made it possible to create glasses that maintain focus at any distance, addressing a wide range of vision challenges across healthcare, entertainment, and beyond.
We offer technology licensing to various companies for a "perfect alcohol-based sanitizer" effective against food poisoning bacteria that are resistant to standard alcohol sanitizers. The reason these bacteria survive even at 100℃ is their ability to synthesize a robust structure called a spore. We have discovered that substance Y inhibits spore formation, and by incorporating it into alcohol-based sanitizers sterilization becomes possible. Furthermore, substance Y is safe and secure; when added to food products, the bacteria can be killed by heating at 100℃. We are therefore also proposing a new sterilization method.
Cells in living organisms function in an orderly manner by cooperating with surrounding cells while interacting with extracellular proteins. However, in cell culture systems, extracellular proteins are largely absent, making it difficult for cells to function properly and often causing them to exhibit physiological activities that differ from those observed in vivo. Our company conducts research on extracellular matrix proteins located outside the cell, and by applying the findings from this research to cell culture technologies, we aim to contribute to the advancement of regenerative medicine and the realization of alternatives to animal experimentation.